Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors. 2013

Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
Medicinal Chemistry 2, Institut Pasteur Korea, Sampyeong-dong 696, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, Republic of Korea.

We identified a novel class of triazolothienopyrimidine (TTPM) compounds as potent HIV-1 replication inhibitors during a high-throughput screening campaign that evaluated more than 200,000 compounds using a cell-based full replication assay. Herein, we report the optimization of the antiviral activity in a cell-based assay system leading to the discovery of aryl-substituted TTPM derivatives (38, 44, and 45), which exhibited significant inhibition of HIV-1 replication with acceptable safety margins. These novel and potent TTPMs could serve as leads for further development.

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D057166 High-Throughput Screening Assays Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays. High-Throughput Screening,High-Throughput Biological Assays,High-Throughput Chemical Assays,High-Throughput Screening Methods,Assay, High-Throughput Biological,Assay, High-Throughput Chemical,Assay, High-Throughput Screening,Biological Assay, High-Throughput,Chemical Assay, High-Throughput,High Throughput Biological Assays,High Throughput Chemical Assays,High Throughput Screening,High Throughput Screening Assays,High Throughput Screening Methods,High-Throughput Biological Assay,High-Throughput Chemical Assay,High-Throughput Screening Assay,High-Throughput Screening Method,High-Throughput Screenings,Screening Assay, High-Throughput,Screening Method, High-Throughput,Screening, High-Throughput
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
July 2005, Bioorganic & medicinal chemistry letters,
Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
November 2016, Medicinal chemistry (Shariqah (United Arab Emirates)),
Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
March 2009, Bioorganic & medicinal chemistry,
Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
April 2013, Bioorganic & medicinal chemistry,
Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
October 2022, European journal of medicinal chemistry,
Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
July 2004, Antiviral chemistry & chemotherapy,
Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
January 2014, The open medicinal chemistry journal,
Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
December 2020, Journal of enzyme inhibition and medicinal chemistry,
Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
February 2017, Bioorganic & medicinal chemistry letters,
Junwon Kim, and Jeongjin Kwon, and Doohyun Lee, and Suyeon Jo, and Dong-Sik Park, and Jihyun Choi, and Eunjung Park, and Jong Yeon Hwang, and Yoonae Ko, and Inhee Choi, and Moon Kyeong Ju, and JiYe Ahn, and Junghwan Kim, and Sung-Jun Han, and Tae-Hee Kim, and Jonathan Cechetto, and Jiyoun Nam, and Sujin Ahn, and Peter Sommer, and Michel Liuzzi, and Zaesung No, and Jinhwa Lee
May 2013, Molecular diversity,
Copied contents to your clipboard!